Colorectal cancer (CRC) is one of the most common cancers in the world. About two third of
patients with CRC will develop distant recurrence at some point in time. Liver is the most …

Colorectal cancer liver metastases (CRLM) represent most of the causes of death in patients
with colorectal cancer. Surgical resection is the only treatment that can provide the …

In the USA, cancers of the colon and rectum are the third most common site of new cancer
cases and cancer deaths. With improved screening and adjuvant therapy, the survival of …

Colorectal carcinoma (CRC) is the third most common cancer, and approximately 35%-55%
of patients with CRC will develop hepatic metastases during the course of their disease …

Background Metastases to the liver is the leading cause of death in patients with colorectal
cancer. Methods The authors review the data on diagnosis and management of this clinical …

Background: Over 50% of patients with colorectal cancer will develop liver metastases. Only
a minority of patients present with technically resectable disease. Around 40% of those …

Abstract Approximately 50%–60% of patients with colorectal cancers will develop liver
lesions in their life span. Despite the potential of surgical resection to provide long-term …

Liver metastasis is the most common site of colorectal cancer (CRC) metastasis.
Approximately half of all colorectal cancer patients will develop liver metastases. Although …

For patients with colorectal liver metastases, hepatic resection is the treatment of choice, and
the 5-year survival rate following surgery now exceeds 50%. Timely multidisciplinary and …

Surgical resection remains one of the major curative treatment options available to patients
with colorectal liver metastases. Surgery and chemotherapy form the backbone of the …